
J Neuropsychiatry Clin Neurosci 17:391-398, August 2005
doi: 10.1176/appi.neuropsych.17.3.391
© 2005 American Neuropsychiatric Association
Evidence for Sustained Attention and Working Memory in Schizophrenia Sharing a Common Mechanism
Henry Silver, MBBS, B.MED SCI, DPM, FRANZCP and
Pablo Feldman, M.D.
Received July 15, 2003; revised April 18, 2004; accepted April 22, 2004. From the Brain Behavior Laboratory, Shaar Menashe Mental Health Center, Mobile Post Hefer 38814, Israel; the Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel. Address correspondence to Dr. Silver, Deputy Director, Shaar Menashe Mental Health Center, And Director, Brain Behavior Laboratory, Mobile Post Hefer 38814, Israel; mdsilver{at}tx.technion.ac.il (E-mail).
Sustained attention and working memory (WM) are closely related functions that may share common mechanisms. The authors assessed sustained attention in schizophrenia patients and healthy comparison subjects using visuomotor tracking tasks under varying distractor loads. The attentional effort expended to deal with distractors was lower in patients and showed significant association with WM, executive function and negative symptoms in that group. It is proposed that the anterior attention system of sustained attention models and the executive function of the WM model describe the same or a closely related mechanism that is located in the prefrontal cortex (PFC) and is impaired in schizophrenia.
This article has been cited by other articles:

|
 |

|
 |
 
H. M. Morris, T. Hashimoto, and D. A. Lewis
Alterations in Somatostatin mRNA Expression in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia or Schizoaffective Disorder
Cereb Cortex,
July 1, 2008;
18(7):
1575 - 1587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Honey, P. R. Corlett, A. R. Absalom, M. Lee, E. Pomarol-Clotet, G. K. Murray, P. J. McKenna, E. T. Bullmore, D. K. Menon, and P. C. Fletcher
Individual Differences in Psychotic Effects of Ketamine Are Predicted by Brain Function Measured under Placebo
J. Neurosci.,
June 18, 2008;
28(25):
6295 - 6303.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2005
American Neuropsychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|